Abstract
Background
Crosstalk between tumor cells and their microenvironment plays a crucial role in the progression of hepatocellular carcinoma (HCC). Hypoxia, a common feature of advanced HCC, has been shown to modulate the evolution of the tumor microenvironment. In this study, we investigated the effect of hypoxia on tumor-stroma crosstalk in HCC.
Methods
Human HCC cell lines (Huh-BAT, SNU-475) were cocultured with an activated human hepatic stellate cell line (HSCs; LX-2) under either normoxic or hypoxic conditions. Cell growth was evaluated with the MTS assay. Apoptotic signaling cascades were assessed by immunoblot analysis. Expression of CD31 and phosphorylated (p-) Akt in HCC tissues was detected by immunohistochemistry.
Results
Coculturing HCC cells with HSCs under hypoxic conditions enhanced their proliferation, migration, and resistance to bile acid (BA)-induced apoptosis compared to coculturing under normoxic conditions. Under hypoxia, of various HSC-derived growth factors, PDGF-BB was the most up-regulated, leading to the activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway in HCC cells. Immunohistochemical study also revealed that p-Akt was highly expressed in hypoxic, hypovascular HCC as compared to hypervascular HCC. Neutralizing antisera to PDGF-BB or a PI3K inhibitor attenuated the proliferation of HCC cells cocultured with HSCs, and sensitized HCC cells to BA-induced apoptosis, especially under hypoxic conditions.
Conclusions
In conclusion, hypoxic HSC-derived PDGF-BB stimulates the proliferation of HCC cells through activation of the PI3K/Akt pathway, while the inhibition of PDGF-BB or PI3K/Akt pathways enhances apoptotic cell death. Targeting tumor-stroma crosstalk might be a novel therapy in the management of human HCCs.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Hepatocellular carcinoma (HCC) is one of the most fatal of cancers with an increasing global incidence [1]. The majority of HCC patients are treated for chronic liver disease or liver cirrhosis (LC), both of which are major risk factors for the development of HCC [2].
A remodeling of the microenvironment of liver in the patients with chronic liver disease or LC is a hallmark of HCC [3]. It is well known that activation of hepatic stellate cells (HSCs) plays a vital role in the development of hepatic fibrosis. In addition, crosstalk between HCC cells and the surrounding microenvironment is believed to play a pivotal role in modulating the biological behavior of the tumor [4, 5]. During chronic liver damage, HSCs become activated and assume a myofibroblast-like phenotype. These cells proliferate and migrate towards the area of ongoing tissue remodeling and secrete extracellular matrix proteins [6]. Moreover, the stroma of the HCC is infiltrated by both activated HSCs and myofibroblasts. The interaction between them affects HCC development by triggering cell proliferation and survival of surrounding tissues [4, 7].
Hypoxia induces survival in HCC by activating a variety of growth factor signals. Hypoxia stimulates angiogenesis by hypoxia-inducible factor-1 (HIF-1), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and angiopoietin-1 (ANG-1) [8]. In addition, hypoxia stimulates HCC cell proliferation by inducing transforming growth factor-β (TGF-β) and platelet derived growth factor (PDGF), facilitates glycolysis by up-regulating hexokinase-II expression [9, 10], induces the immortalization of HCC cells by activating telomerase and histone deacetylase [11], and inhibits cellular apoptosis by inducing the inhibitor of apoptosis protein-2 (IAP-2) and myeloid cell factor-1 (Mcl-1) [12]. Therefore, under hypoxic conditions, the microenvironment may undergo dramatic changes mediated by various cytokines and growth factors, which lead to tumor growth, and metastasis.
However, the molecular mechanisms involved, and the consequences of any crosstalk between tumor cells and activated HSCs, especially under hypoxic conditions, remain largely unknown [13]. The current study investigated the effects of hypoxia on tumor-stroma crosstalk in HCC.
Methods
Cell Lines and Coculture
Human HCC cell lines and a hepatic stellate cell line were used in this study: Huh-BAT, a well-differentiated, bile acid transporter-transfected HCC cell line [14]; SNU-475, a poorly differentiated HCC cell line [15]; and LX-2, an activated, human HSC line [16]. Cells were grown in Dulbecco’s Modified Eagle Medium (DMEM, Huh-BAT, and LX-2) or in RPMI 1640 (SNU-475) supplemented with 10 % fetal bovine serum (FBS), 100,000 U/L penicillin, and 100 mg/L streptomycin, with or without 100 nM insulin. Coculture experiments were performed in serum-free DMEM or RPMI 1640 using 1-μm pore size transwell inserts (Corning; Lowell, MA, USA). Transwell inserts permitted diffusion of media; however, they prevented cell migration. HCC and LX-2 cell lines were incubated alone, or side-by-side, using transwell inserts under either standard (20 % O2 and 5 % CO2, at 37 °C) or hypoxic (1 % O2, 5 % CO2, and 94 % N2, at 37 °C) culture conditions.
Cell Proliferation Analysis
Cell growth was measured colorimetrically using a CellTiter 96® AQueous One Solution Cell Proliferation Assay (Promega Corporation; Madison, WI, USA). Briefly, this assay requires cellular conversion of 3,4-(5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt (MTS) into soluble formazan by dehydrogenase enzymes produced only by metabolically active, proliferating cells. Following each treatment, 20 μL of CellTiter 96® AQueous One Solution reagent was added to each well of a 96-well plate. After an 1 h incubation, the absorbance of each well was measured at a 490 nm wavelength using an ELISA plate reader (Molecular Devices; Sunnyvale, CA).
Migration Assay
Migration was assessed by using a time-lapse scratch assay (wound-healing-assay). Briefly, HCC cells were seeded at high density into 6-well plates. Following adherence, cells were washed with serum-free DMEM and incubated in either control medium or medium derived from activated HSCs. The cell layer was scratched with a pipette tip and the degree of cell migration measured after 24 and 48 h. Each analysis was performed in triplicate and repeated three times.
Apoptosis Analysis
Chromatic condensation and nuclear fragmentation were assessed using a DNA binding dye, 40,6-diamidino-2-phenylindole dihydrochloride (DAPI), and fluorescence microscopy (Carl Zeiss; Jena, Germany).
Quantification of Growth Factors
The mRNA expressions of human fibroblast growth factor 10 (FGF10), fibroblast growth factor 5 (FGF5), connective tissue growth factor (CTGF), transforming growth factor-ß1 (TGF-ß1), and platelet-derived growth factor beta polypeptide (PDGF-B) were assessed using a real-time reverse-transcriptase polymerase chain reaction (RT-PCR). Total ribonucleic acids (RNAs) were extracted from cells using Trizol Reagent (Invitrogen, Carlsbad, CA). Complementary deoxyribonucleic acid (cDNA) templates were prepared using oligo(dT) random primers and Moloney Murine Leukemia Virus (MoMLV) reverse transcriptase. After the reverse transcription reaction, the cDNA template was amplified by PCR using Taq polymerase (Invitrogen). Relative quantification was calculated using the \( 2^{{ - \varDelta \varDelta C_{T} }} \) method, with GAPDH as the internal control. All PCR experiments were performed in triplicate. In addition, the amount of PDGF-BB in cell culture supernatants was assessed by an ELISA kit (R&D Systems; Abingdon, UK).
Immunoblot Assay
Antibodies against: caspase-9, caspase-8, cleaved caspase-7, PDGFR-β, phosphorylated (p-) PDGFR-β (Tyr 751), total Akt, p-Akt (Ser473), total phosphatase and tensin homolog deleted on chromosome ten (PTEN), p-PTEN (Ser380/Thr382/383), total-p42/44 (Thr202/Tyr204), p-p42/44, p-p38 (Thr180/Tyr182), total Forkhead transcription factor (FOXO)3a, and p-FOXO3a were purchased from Cell Signaling (Beverly, MA, USA). Cells were lysed for 20 min on ice using lysis buffer (50 mM Tris–HCl, pH 7.4; 1 % Nonidet P-40; 0.25 % sodium deoxycholate; 150 mM NaCl; 1 mM EDTA; 1 mM phenylmethylsulfonylfloride; aprotinin, leupeptin, and pepstatin (1 µg/mL each); 1 mM Na3VO4; and 1 mM NaF) and centrifuged at 14,000×g for 15 min at 4 °C. Samples were resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis, transferred to nitrocellulose membranes, blotted with the appropriate primary antibodies, and incubated with peroxidase-conjugated secondary antibodies (Biosource International; Camarillo, CA). Bound antibodies were visualized using a chemiluminescent substrate (ECL; Amersham; Arlington Heights, IL) and exposed to Kodak X-OMAT film. The images were detected using an image analyzer (LAS-1000, Fuji Photo Film, Tokyo, Japan), and densitometric analyses were performed using ImageJ software (National Institutes of Health, Bethesda, MD).
Immunohistochemical Study
Four representative human hypervascular and hypovascular HCC tissues used in our previous study were analyzed [17]. Tumor vascularity was assessed according to the arterial enhancement patterns on dynamic computed tomography (CT) and vascular appearance at the tissue by CD31 immunohistochemical (IHC) staining. IHC was performed according to the manufacturer’s protocol using the anti-mouse CD31 antibody (Vector Laboratories, Inc., Burlingame) at a 1:200 dilution or anti-rabbit-p-Akt antibody (Cell Signaling, Beverly, MA) at 1:100 dilution [18]. The study protocol was reviewed and approved by the Institutional Review Board of Seoul National University Hospital (IRB No. 1003-099-314).
Data Analysis
All experimental results were acquired from three independent experiments and are presented as mean ± standard deviation (SD). Comparisons between groups were analyzed using the Mann–Whitney U test and P < 0.05 was considered statistically significant. All analyses were conducted using SPSS version 22.0 (SPSS Inc.; Chicago, IL, USA).
Results
Enhanced Cell Proliferation and Migration by Coculturing in Hypoxia
Initially, we examined whether coculturing HCC cells with HSCs under hypoxic conditions could modulate the proliferation and migration of cells. Compared with HCC cells (Huh-BAT or SNU-475) cultured alone, coculturing with LX-2 cells significantly increased the proliferation of HCC cells, which was further augmented under hypoxic conditions (Fig. 1). In addition, coculturing HCC cells with LX-2 cells under hypoxia significantly accelerated the migration of HCC cells compared with coculturing under normoxia (Fig. 2).
Decreased Bile Acid-Induced HCC Cell Apoptosis
Next, we evaluated the effect of coculture conditions on cellular apoptosis. As reported previously, hypoxia enhances resistance to bile acid (BA)-induced apoptosis [10]. Huh-BAT cells cocultured with LX-2 cells were significantly more resistant to BA-induced HCC cell apoptosis compared to monocultured cells, especially under hypoxic conditions (Fig. 3a). Western blot analyses confirmed that coculturing with LX-2 cells attenuated BA-induced activation of caspase-9, -8 and -7 in Huh-BAT cells, under hypoxic conditions (Fig. 3b).
The Effects of Hypoxic HSC-Derived PDGF-BB on HCC Cells
We evaluated mRNA expression of HSC-derived, HCC-relevant growth factors such as TGF-β1, FGF5 and 10, CTGF, and PDGF-B in LX-2 cells (Fig. 4a). Among the growth factors tested, PDGF-B exhibited the most significant fold-change in mRNA expression levels under hypoxic conditions. Furthermore, LX-2 cells secreted significantly higher levels of PDGF-BB protein under hypoxic conditions (Fig. 4b).
To evaluate whether PDGF-BB can reproduce the cytoprotective effects of hypoxic coculture condition on HCC cells, Huh-BAT cells were treated with exogenous PDGF-BB under normoxic conditions. PDGF-BB significantly enhanced proliferation (Fig. 5a) and migration of Huh-BAT cells (Fig. 5b).
In addition, PDGF-BB protected HCC cells from BA-induced apoptosis (Fig. 5c), especially under hypoxic conditions. When Huh-BAT cells were treated with neutralizing antiserum to PDGF-BB, the proliferation of cocultured cells under hypoxia significantly decreased compared to the proliferation of cocultured cells under normoxia (Fig. 5d). Anti-PDGF-BB also sensitized Huh-BAT cells to BA-induced apoptosis, especially under hypoxic conditions (Fig. 5e). These results suggest HSC-derived PDGF-BB promotes proliferation and resistance to apoptosis of HCC cells, especially under hypoxic conditions.
In response to the upregulation of PDGF-BB, phosphorylation of PDGFR-β was enhanced in Huh-BAT cells cocultured with LX-2 cells under hypoxia (Fig. 6a). Given that Ras-p42/44 mitogen-activated protein kinase (MAPK) pathways and the phosphatidylinositol 3-kinase (PI3K)/Akt pathway are important downstream pathways of PDGFR-β, we evaluated the expression of p-p42/44 and p-Akt. As shown in Fig. 6b, coculturing with LX-2 cells under hypoxic conditions augmented the activation of Akt and p42/44 in Huh-BAT cells. Akt-dependent phosphorylation of FOXO3a was also up-regulated. In contrast, the expression levels of p-p38, total Akt, total PTEN, and p-PTEN were not affected. When Huh-BAT cells were treated with PI3K inhibitor (LY294002), the proliferation of cocultured cells under hypoxia significantly decreased compared to that under normoxia (Fig. 6c), whereas p42/44 inhibitor (U0126) did not significantly affect cell proliferation.
IHC study using human HCC tissues also revealed that p-Akt was highly expressed in hypoxic, hypovascular HCC as compared to hypervascular HCC (Fig. 7). Taken together, these findings suggest that hypoxic HSC-derived PDGF-BB promotes HCC progression, mainly via activation of the PI3K/Akt pathway.
Discussion
HCC cells under hypoxic conditions generally show more rapid proliferation than cells with an adequate vascular supply [19]. It has been reported that HSCs play a critical role in HCC tumor progression, as the presence of HSCs in peritumoral tissue is associated with strong vascular invasion and aggressive pathological characteristics [20]. However, the manner in which HSCs modulate the invasive HCC phenotype, particularly under hypoxic conditions, remains unclear.
In the present study, activated HSCs induced the proliferation and migration of HCC cells, and suppressed BA-induced HCC cell apoptosis, particularly under hypoxic conditions. The anti-proliferative effects of PI3K inhibitor on HCC cells cocultured with HSCs were more prominent under hypoxic conditions, indicating that the PI3K/Akt pathway may be implicated in tumor progression under hypoxic conditions, more so than tumor progression under normoxic conditions. Akt-dependent inhibitory phosphorylation of FOXO3a was also up-regulated under hypoxia, which may lead to HCC cell survival.
The PI3K/Akt pathway is a well-known, promising target for the treatment of HCC, which has its pivotal role in regulating cell proliferation, migration, survival, and angiogenesis. Dysregulation of PI3K/Akt pathway in HCC has been frequently documented [21]. Furthermore, the PI3K/Akt pathway also induces the activation and proliferation of HSCs, leading to the development of fibrosis and HCC in PDGF-C transgenic mice [22], suggesting that this molecular pathway may be critical in hepatocarcinogenesis. Similarly, our results suggest that the PI3K/Akt pathway is crucial in proliferation and invasion of HCC, especially under hypoxic conditions.
PGDF consists of two related peptide chains, PDGF-A and PDGF-B, which contain intramolecular disulfide bonds linking the subunits. Of the isoforms of PDGF, the PDGF-BB isoform is a mitogen for vascular smooth muscle cells [23], and is one of the key factors involved in hepatocarcinogenesis. A recent study reported that the overexpression of PDGF-BB accelerated hepatic fibrosis and chemically induced hepatocarcinogenesis by upregulation of the TGF-β receptor, β-catenin, and vascular endothelial growth factor in transgenic mice [24]. Likewise, exogenous PDGF-BB enhanced proliferation and migration of HCC cells, and protected cells from BA-induced apoptosis in our study. In addition, the levels of PDGF-BB derived from HSCs were significantly upregulated under hypoxic conditions, leading to the enhanced activation of PDGFR-β, p42/44 MAPK, and PI3K/Akt pathways in HCC cells. These findings suggest that hypoxic HSC-derived PDGF-BB induces HCC progression through the activation of PI3K/Akt and p42/44 MAPK signaling pathways, as a consequence of tumor-stroma crosstalk under hypoxic conditions. These results further suggest that targeting the PI3K pathway or PDGF receptor may enhance the efficacy of chemotherapeutic agents against HCC in a hypoxic microenvironment.
In conclusion, the current study indicates that hypoxic HSC-derived PDGF-BB stimulates HCC cell proliferation and attenuates BA-induced apoptosis in a PI3K/Akt-signaling-dependent manner. Targeting tumor-stroma crosstalk might be a novel therapy in the management of human HCC.
Abbreviations
- HCC:
-
Hepatocellular carcinoma
- HSC:
-
Hepatic stellate cell
- MTS:
-
3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxy-methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
- DAPI:
-
4′,6-Diamidino-2-phenylindole
- BA:
-
Bile acid
- ELISA:
-
Enzyme-linked immunosorbent assay
- RT-PCR:
-
Reverse transcription-polymerase chain reaction
- Akt:
-
Protein kinase B
- PTEN:
-
Phosphatase and tensin homolog
- PI3K:
-
Phosphoinositide 3-kinase
- PDGF:
-
Platelet-derived growth factor
- FGF:
-
Fibroblast growth factor
- TGF:
-
Transforming growth factor
- CTGF:
-
Connective tissue growth factor
- MAPK:
-
Mitogen-activated protein kinase
- OD:
-
Optical density
- SD:
-
Standard deviation
- IHC:
-
Immunohistochemical
- FOXO:
-
Forkhead transcription factors
References
El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127:S27–S34.
Bruix J, Boix L, Sala M, Llovet JM. Focus on hepatocellular carcinoma. Cancer Cell. 2004;5:215–219.
Theret N, Musso O, Turlin B, et al. Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology. 2001;34:82–88.
Eiro N, Vizoso FJ. Importance of tumor/stroma interactions in prognosis of hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2014;3:98–101.
Coulouarn C, Clement B. Stellate cells and the development of liver cancer: therapeutic potential of targeting the stroma. J Hepatol. 2014;60:1306–1309.
Pinzani M, Macias-Barragan J. Update on the pathophysiology of liver fibrosis. Expert Rev Gastroenterol Hepatol. 2010;4:459–472.
Gupta DK, Singh N, Sahu DK. TGF-beta mediated crosstalk between malignant hepatocyte and tumor microenvironment in hepatocellular carcinoma. Cancer Growth Metastasis. 2014;7:1–8.
Lee HJ, Kang HJ, Kim KM, et al. Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma. Clin Mol Hepatol. 2015;21:60–70.
Lal A, Peters H, St Croix B, et al. Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst. 2001;93:1337–1343.
Gwak GY, Yoon JH, Kim KM, Lee HS, Chung JW, Gores GJ. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression. J Hepatol. 2005;42:358–364.
Kim MS, Kwon HJ, Lee YM, et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med. 2001;7:437–443.
Stoeltzing O, Ahmad SA, Liu W, et al. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. Cancer Res. 2003;63:3370–3377.
Lee JS. The mutational landscape of hepatocellular carcinoma. Clin Mol Hepatol. 2015;21:220–229.
Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 1982;42:3858–3863.
Park JG, Lee JH, Kang MS, et al. Characterization of cell lines established from human hepatocellular carcinoma. Int J Cancer. 1995;62:276–282.
Xu L, Hui AY, Albanis E, et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut. 2005;54:142–151.
Chung GE, Lee JH, Yoon JH, et al. Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma. Abdom Imaging. 2012;37:439–446.
Liang Y, Zheng T, Song R, et al. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel–Lindau tumor suppressor-dependent HIF-1alpha inhibition in hepatocellular carcinoma. Hepatology. 2013;57:1847–1857.
Tezuka M, Hayashi K, Kubota K, et al. Growth rate of locally recurrent hepatocellular carcinoma after transcatheter arterial chemoembolization: comparing the growth rate of locally recurrent tumor with that of primary hepatocellular carcinoma. Dig Dis Sci. 2007;52:783–788.
Amann T, Bataille F, Spruss T, et al. Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci. 2009;100:646–653.
Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer. 2009;9:550–562.
Campbell JS, Hughes SD, Gilbertson DG, et al. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA. 2005;102:3389–3394.
Vaillancourt RR, Gardner AM, Kazlauskas A, Johnson GL. The kinase-inactive PDGF beta-receptor mediates activation of the MAP kinase cascade via the endogenous PDGF alpha-receptor in HepG2 cells. Oncogene. 1996;13:151–159.
Maass T, Thieringer FR, Mann A, et al. Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis. Int J Cancer. 2011;128:1259–1268.
Acknowledgments
This study was supported by a grant from the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1420050), and by the Liver Research Foundation of Korea.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors disclose no conflicts of interest.
Additional information
Yuri Cho and Eun Ju Cho have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Cho, Y., Cho, E.J., Lee, JH. et al. Hypoxia Enhances Tumor-Stroma Crosstalk that Drives the Progression of Hepatocellular Carcinoma. Dig Dis Sci 61, 2568–2577 (2016). https://doi.org/10.1007/s10620-016-4158-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-016-4158-6